Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Chang XS"" wg kryterium: Autor


Wyświetlanie 1-5 z 5
Tytuł:
Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with ALK-rearranged: a meta-analysis of clinical trials.
Autorzy:
Ma HC; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Liu YH; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Ding KL; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Liu YF; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Zhao WJ; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Zhu YJ; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.; Guangdong Provincial Key Laboratory, of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, 510120, China.
Chang XS; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Chen YD; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Xiao ZZ; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Yu YY; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.
Zhou R; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China.; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.
Zhang HB; Department of Oncology, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, 510120, China. .; The Second Clinical Medical School, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. .; Guangdong-Hong Kong-Macau Joint Lab on Chinese Medicine and Immune Disease Research, Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. .; Guangdong Provincial Key Laboratory, of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou, 510120, China. .; State Key Laboratory of Dampness Syndrome of Chinese Medicine, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China. .
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2021 Nov 26; Vol. 21 (1), pp. 1278. Date of Electronic Publication: 2021 Nov 26.
Typ publikacji:
Comparative Study; Journal Article; Meta-Analysis; Systematic Review
MeSH Terms:
Gene Rearrangement*
Anaplastic Lymphoma Kinase/*genetics
Antineoplastic Agents/*therapeutic use
Carcinoma, Non-Small-Cell Lung/*drug therapy
Lung Neoplasms/*drug therapy
Protein Kinase Inhibitors/*therapeutic use
Aminopyridines/adverse effects ; Aminopyridines/therapeutic use ; Antineoplastic Agents/adverse effects ; Carbazoles/adverse effects ; Carbazoles/therapeutic use ; Carcinoma, Non-Small-Cell Lung/genetics ; Carcinoma, Non-Small-Cell Lung/mortality ; Carcinoma, Non-Small-Cell Lung/pathology ; Clinical Trials, Phase II as Topic ; Clinical Trials, Phase III as Topic ; Humans ; Lactams/adverse effects ; Lactams/therapeutic use ; Lung Neoplasms/genetics ; Lung Neoplasms/mortality ; Lung Neoplasms/pathology ; Network Meta-Analysis ; Organophosphorus Compounds/adverse effects ; Organophosphorus Compounds/therapeutic use ; Piperazines/adverse effects ; Piperazines/therapeutic use ; Piperidines/adverse effects ; Piperidines/therapeutic use ; Progression-Free Survival ; Protein Kinase Inhibitors/adverse effects ; Pyrazoles/adverse effects ; Pyrazoles/therapeutic use ; Pyridazines/adverse effects ; Pyridazines/therapeutic use ; Pyrimidines/adverse effects ; Pyrimidines/therapeutic use ; Randomized Controlled Trials as Topic ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Adropin inhibits the phenotypic modulation and proliferation of vascular smooth muscle cells during neointimal hyperplasia by activating the AMPK/ACC signaling pathway.
Autorzy:
Wang L; Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215151, P.R. China.; Emergency Department, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215151, P.R. China.
Zhao LP; Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215151, P.R. China.
Chen YQ; Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215151, P.R. China.
Chang XS; Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215151, P.R. China.
Xiong H; Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215151, P.R. China.
Zhang DM; Department of Cardiology, Nanjing First Hospital, Nanjing, Jiangsu 210006, P.R. China.
Xu WT; Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215151, P.R. China.
Chen JC; Department of Cardiology, The Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215151, P.R. China.
Pokaż więcej
Źródło:
Experimental and therapeutic medicine [Exp Ther Med] 2021 Jun; Vol. 21 (6), pp. 560. Date of Electronic Publication: 2021 Mar 26.
Typ publikacji:
Journal Article
Czasopismo naukowe
    Wyświetlanie 1-5 z 5

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies